Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTZ Paste vs ZOE Pulpectomy in Emergency Dental Treatments
NCT07542639Phase 1Not yet recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of chloramphenicol + tetracycline + zinc oxide in pulp necrosis and irreversible pulpitis (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Pain Resolution and Clinical Infection Control at 12 months. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
chloramphenicol + tetracycline + zinc oxide
03
Conditions
pulp necrosisirreversible pulpitis
Beyond the preview
Go deeper on NCT07542639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07542639.